Study of the Effects of Muscular Activity on Iron Metabolism

Sponsor
Rennes University Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT00378469
Collaborator
(none)
14
2
7

Study Details

Study Description

Brief Summary

The aim of this study is to evaluate the effect of muscular exercise on iron metabolism in healthy volunteers. Fourteen healthy male subjects will have to pedal on an ergocycle for 45 minutes, and urine and blood samples will be collected regularly to measure hemojuvelin, hepcidin, iron and transferrin levels.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: 45 minute exercise on ergocycle
N/A

Detailed Description

Hemojuvelin has been described as interfering with hepcidin, a key regulator of iron homeostasis. Hemojuvelin is mainly produced by muscle, and the relationship between exercise and iron metabolism can be questioned about.

The aim of this study is to evaluate the effect of muscular exercise on iron metabolism in healthy volunteers. Fourteen healthy male subjects will be investigated at two periods according to a cross-over design after:

  1. 45 minutes of exercise on the ergocycle; and

  2. no physical exercise.

Urine and blood samples will be collected at both periods regularly to measure hemojuvelin, hepcidin, iron and transferrin levels.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
14 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Official Title:
Study of the Effects of Muscular Activity on Iron Metabolism: A Pilot Study on Healthy Volunteers
Study Start Date :
Sep 1, 2006

Outcome Measures

Primary Outcome Measures

  1. Pharmacokinetics of urinary hepcidin []

  2. Pharmacokinetics of blood hemojuvelin []

Secondary Outcome Measures

  1. Pharmacokinetics of urine and blood iron, transferrin, interleukin-6 (IL-6) and ferritin []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Male individuals aged between 18 and 40 years old

  • Body mass index (BMI) between 18 and 25

  • Normal at clinical examination

  • Normal biological variables

  • Written informed consent

Exclusion Criteria:
  • Mutation C282Y of the HFE gene

  • Iron metabolism abnormality

  • Inflammatory syndrome

  • Chronic pathology or ongoing treatment

  • Tobacco smoking, alcohol consuming more than 30g/day

  • History of transfusion or blood-giving within 3 months

  • Positive serology for hepatitis B virus (HBV), hepatitis C virus (HCV) or HIV.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Service des Maladies du Foie - Hôpital de Pontchaillou Rennes France 35033
2 Unité de Biologie et Médecine du Sport - Hôpital de Pontchaillou Rennes France 35033

Sponsors and Collaborators

  • Rennes University Hospital

Investigators

  • Principal Investigator: Pierre Brissot, MD, Rennes University Hospital
  • Study Chair: Bruno Laviolle, MD, Rennes University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00378469
Other Study ID Numbers:
  • DGS 2006/0415
  • LOC/05-07
  • CIC0203/061
First Posted:
Sep 20, 2006
Last Update Posted:
Jul 12, 2007
Last Verified:
May 1, 2007
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 12, 2007